L. Jarvis

发表

Investigation of chronic hepatitis C infection in individuals with haemophilia: assessment of invasive and non‐invasive methods

P. Simmonds, J. Hanley, R. Lee, 1996, British journal of haematology.

Seroprevalence of lyme borreliosis in Scottish blood donors

H. Munro, R. Evans, K. Duffy, 2015, Transfusion medicine.

Evolutionary remodelling of N‐terminal domain loops fine‐tunes SARS‐CoV‐2 spike

A. Shepherd, M. Reeves, G. Towers, 2022, EMBO reports.

Development of anti‐interferon antibodies and breakthrough hepatitis during treatment for HCV infection in haemophiliacs

P. Simmonds, J. Hanley, C. Ludlam, 1996, British journal of haematology.

Comparison of SARS-CoV-2 serological assays for use in epidemiological surveillance in Scotland

P. Bieniasz, D. Poston, S. Jenks, 2021, Journal of Clinical Virology Plus.

Multicenter evaluation of the new Alinity s anti-HCV II assay for routine hepatitis C virus blood screening

W. Tsoi, L. Jarvis, Ninette F. Robbins, 2023, Journal of Clinical Virology Plus.

Sexual transmission of GB virus C/hepatitis G virus

P. Simmonds, D. Clutterbuck, G. Scott, 1998, Journal of medical virology.

Patterns of Hepatitis G Viraemia and Liver Disease in Haemophiliacs Previously Exposed to Non-virus Inactivated Coagulation Factor Concentrates

P. Simmonds, J. Hanley, C. Ludlam, 1998, Thrombosis and Haemostasis.

Fatal COVID-19 outcomes are associated with an antibody response targeting epitopes shared with endemic coronaviruses

P. Klenerman, P. Phalora, G. Screaton, 2021, medRxiv.

Combination therapy of infliximab and thiopurines, but not monotherapy with infliximab or vedolizumab, is associated with attenuated IgA and neutralisation responses to SARS-CoV-2 in inflammatory bowel disease

J. Satsangi, P. Klenerman, P. Simmonds, 2021, Gut.

Variation of the hepatitis C virus 5' non-coding region: implications for secondary structure, virus detection and typing. The International HCV Collaborative Study Group.

P. Simmonds, P. Yap, M. Urdea, 1995, The Journal of general virology.

National population prevalence of antibodies to SARS-CoV-2 in Scotland during the first and second waves of the COVID-19 pandemic

T. McNeilly, L. Wallace, P. Murcia, 2021, Public Health.

Neutralising antibodies to SARS coronavirus 2 in Scottish blood donors - a pilot study of the value of serology to determine population exposure

P. Klenerman, P. Simmonds, G. Screaton, 2020, medRxiv.